Vivani Medical, Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Vivani Medical, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q3 2024.
  • Vivani Medical, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$6.31M, a 11.7% increase year-over-year.
  • Vivani Medical, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$24.4M, a 14.4% increase year-over-year.
  • Vivani Medical, Inc. annual Operating Income (Loss) for 2023 was -$27M, a 26.9% decline from 2022.
  • Vivani Medical, Inc. annual Operating Income (Loss) for 2022 was -$21.2M, a 59.4% decline from 2021.
  • Vivani Medical, Inc. annual Operating Income (Loss) for 2021 was -$13.3M, a 10.6% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$24.4M -$6.31M +$835K +11.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$25.3M -$5.68M +$1.32M +18.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$26.6M -$6.23M +$374K +5.67% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$27M -$6.22M +$1.59M +20.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$28.6M -$7.14M -$1.7M -31.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$26.9M -$7M -$2.92M -71.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$23.9M -$6.6M -$2.69M -69% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$21.2M -$7.8M -$6.51M -504% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$14.7M -$5.44M -$1.96M -56.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$12.8M -$4.09M -$1.79M -78% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$11M -$3.91M -$1.06M -37.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$9.92M -$1.29M -$17K -1.33% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-29
Q3 2021 -$9.9M -$3.49M -$1.88M -118% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$8.02M -$2.3M +$820K +26.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$8.84M -$2.84M +$6.06M +68.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$14.9M -$1.27M +$6.85M +84.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$21.7M -$1.6M +$6.02M +79% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-29
Q2 2020 -$27.8M -$3.12M +$5.33M +63.1% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-29
Q1 2020 -$33.1M -$8.9M +$864K +8.85% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-29
Q4 2019 -$34M -$8.13M +$751K +8.46% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$34.7M -$7.62M +$927K +10.8% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-16
Q2 2019 -$35.6M -$8.44M -$453K -5.67% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-16
Q1 2019 -$35.2M -$9.77M +$1K +0.01% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-16
Q4 2018 -$35.2M -$8.88M -$1.44M -19.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 -$33.7M -$8.55M -$1.8M -26.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-19
Q2 2018 -$31.9M -$7.99M -$1.12M -16.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-19
Q1 2018 -$30.8M -$9.77M -$2.21M -29.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-19
Q4 2017 -$28.6M -$7.43M +$2.95M +28.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-19
Q3 2017 -$31.6M -$6.75M +$1.75M +20.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-19
Q2 2017 -$33.3M -$6.87M +$1.64M +19.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-19
Q1 2017 -$34.9M -$7.56M -$1.73M -29.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-19
Q4 2016 -$33.2M -$10.4M -$4.91M -89.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-20
Q3 2016 -$28.3M -$8.5M -$3.84M -82.3% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-20
Q2 2016 -$24.5M -$8.51M -$3.56M -72% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-20
Q1 2016 -$20.9M -$5.82M -$860K -17.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-20
Q4 2015 -$20M -$5.48M +$88K +1.58% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$20.1M -$4.66M +$987K +17.5% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$21.1M -$4.95M +$616K +11.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$21.7M -$4.96M -$505K -11.3% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$21.2M -$5.57M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$5.65M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-11
Q2 2014 -$5.56M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-11
Q1 2014 -$4.46M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.